Mitsu Chem Plast (540078)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trailing P/E of 12.22 and P/B of 1.97 provide a modest valuation for a small-cap if earnings are maintained.
• Piotroski F-Score of 7/9 signals improving profitability and financial health.
• Latest quarter net profit of ₹5 Cr on ₹86 Cr sales shows positive operating momentum.
• ROE of 12.42% and ROCE of 10.41% are reasonable, though not exceptional.

Concerns

• Profit growth of 224.32% against sales growth of only 6.89% is margin recovery, not durable top-line compounding.
• Debt/Equity is not available, so leverage and balance-sheet risk cannot be properly assessed.
• Promoter holding is not disclosed, leaving no visibility into management's skin in the game.
• Net margin around 5.8% in the latest quarter leaves a thin cushion if input costs or competition rise.

AI Analysis

As an investor, I search for businesses I can understand, with durable economics and a margin of safety. Mitsu Chem Plast is a small-cap packaging company with a market cap of ₹193 Cr. The stock trades at a trailing P/E of 12.22 and a price-to-book of 1.97, so the quoted price is not obviously insane. But a low price is not enough; the business must be sound. The headline profit growth of 224.32% excites, yet I immediately notice sales grew only 6.89%. That gap tells me this is a recovery in margins, not a compounder growing its top line. Latest quarter sales of ₹86 Cr and net profit of ₹5 Cr imply a thin net margin of about 5.8%, typical of a competitive packaging industry with limited pricing power. ROE of 12.42% and ROCE of 10.41% are respectable but not exceptional; they do not suggest a wide moat. I cannot see debt/equity or promoter holding, which troubles me. I would not buy without understanding leverage and insider ownership. The Piotroski score of 7 out of 9 is a point in favour, suggesting recent fundamentals are improving. The dividend yield is negligible at 0.19%, so returns must come from reinvestment and capital appreciation. At P/E 12.22, the market is cautious, and I should be too. The PEG ratio of 0.11 looks wonderful only if 224% profit growth is sustainable—it almost certainly is not. I would treat this as a possible turnaround, needing more quarters to prove margins and balance-sheet reliability. Buying here requires faith; I prefer to wait for evidence. Mr. Graham taught me to weigh facts, not hopes.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer